SELLAS Life Sciences Group, Inc. — Director's Dealing 2017

Dec 29, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SELLAS Life Sciences Group, Inc. (SLS)
CIK: 0001390478
Period of Report: 2017-12-29

Reporting Person: Lopez Fabio (Director, 10% Owner)
Reporting Person: EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund (10% Owner)
Reporting Person: EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund (10% Owner)
Reporting Person: EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund` (10% Owner)
Reporting Person: EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund (10% Owner)
Reporting Person: Equilibria Capital Management Ltd (10% Owner)
Reporting Person: Castilian Ltd. (10% Owner)
Reporting Person: Varibobi Financial Holdings Ltd (10% Owner)
Reporting Person: Tafur Daniel (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct